Ernexa Therapeutics Inc. (ERNAW) Operating cash flow 2016–2025
Ernexa Therapeutics Inc. (ERNAW) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$7.0MFY2025 · since FY2016: $23,000 → -$7.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$7.0M | +55.7% |
| FY2024 | -$15.8M | +22.4% |
| FY2023 | -$20.4M | +2.7% |
| FY2022 | -$21.0M | +10.7% |
| FY2021 | -$23.5M | -189.9% |
| FY2020 | -$8.1M | -395.2% |
| FY2019 | $2.7M | +101.0% |
| FY2018 | $1.4M | +148.6% |
| FY2017 | $549,000 | +2287.0% |
| FY2016 | $23,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice